BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11384915)

  • 1. SSRI discontinuation and buspirone.
    Carrazana EJ; Rivas-Vazquez RA; Rey JA; Rey GJ
    Am J Psychiatry; 2001 Jun; 158(6):966-7. PubMed ID: 11384915
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome after sertraline, buspirone and loxapine?
    Bonin B; Vandel P; Vandel S; Sechter D; Bizouard P
    Therapie; 1999; 54(2):269-71. PubMed ID: 10394270
    [No Abstract]   [Full Text] [Related]  

  • 3. Discontinuation of antidepressant therapy: emerging complications and their relevance.
    Thompson C
    J Clin Psychiatry; 1998 Oct; 59(10):541-8. PubMed ID: 9818638
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.
    Markowitz JS
    J ECT; 1998 Mar; 14(1):55. PubMed ID: 9661096
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor discontinuation syndrome: putative mechanisms and prevention strategies.
    Rojas-Fernandez C; Gordon J
    Can J Psychiatry; 1998 Jun; 43(5):523-4. PubMed ID: 9653540
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychotic mania in bipolar II depression related to sertraline discontinuation.
    Benazzi F
    Can J Psychiatry; 2002 Aug; 47(6):584-5. PubMed ID: 12211891
    [No Abstract]   [Full Text] [Related]  

  • 8. [Discontinuation syndrome after SSRI antidepressants].
    Lykkegaard LA; Videbech P
    Ugeskr Laeger; 2014 Feb; 176(3):231-5. PubMed ID: 24629750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone as an antidote to SSRI-induced bruxism in 4 cases.
    Bostwick JM; Jaffee MS
    J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
    Spigset O; Adielsson G
    Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline withdrawal in two brothers: a case report.
    Rosenstock HA
    Int Clin Psychopharmacol; 1996 Mar; 11(1):58-9. PubMed ID: 8732316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW; Zitzelsberger A; Klieser E
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthostatic hypotension induced by sertraline withdrawal.
    Amsden GW; Georgian F
    Pharmacotherapy; 1996; 16(4):684-6. PubMed ID: 8840377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
    Schatzberg AF; Haddad P; Kaplan EM; Lejoyeux M; Rosenbaum JF; Young AH; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():23-7. PubMed ID: 9219490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine depletion studies: implications for antidepressant discontinuation syndrome.
    Delgado PL
    J Clin Psychiatry; 2006; 67 Suppl 4():22-6. PubMed ID: 16683859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor elimination half-lives: the long and the short of it.
    Golden RN
    Biol Psychiatry; 1998 Jul; 44(2):75-6. PubMed ID: 9646888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.